CorNeat Vision
PrivateLast Round
Grant
Oct 1, 2021
Total Funding Raised
$11.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CorNeat Vision operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in October 2021.
CorNeat Vision is a healthtech company that develops ophthalmic implants designed for the surgical treatment of corneal blindness and ocular disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CorNeat Vision Comparables
Compare CorNeat Vision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EyeYon Medical | 89% | |
| BioLattice Ophthalmics, Inc. | 87% | |
| KeraMed, Inc. | 86% |
For institutional investors. Book with your work email.
CorNeat Vision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2021 | ||||
| Early Funding | Aug 25, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CorNeat Vision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Medical Technology Enterprise Consortium | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 42% MoM, reaching 4.1K.
- Sep 12, 2025
CorNeat Vision announced unspecified updates for the clinical trial of its CorNeat KPro artificial cornea, including a "groundbreaking clinical achievement" for one of its patients. The article does not provide details on the updates or the achievement.
For institutional investors. Book with your work email.
CorNeat Vision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CorNeat Vision's valuation, stock price, and market status.
Is CorNeat Vision a public or private company?
CorNeat Vision is a private company.
What is the current stock price of CorNeat Vision?
CorNeat Vision is a private company, so its shares have no public market price. Caplight tracks CorNeat Vision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CorNeat Vision worth (valuation)?
Valuation information for CorNeat Vision is not publicly available.
Can I buy CorNeat Vision stock?
CorNeat Vision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CorNeat Vision's last funding round?
CorNeat Vision's most recent funding round was Grant on October 1, 2021.
Who are the main investors in CorNeat Vision?
Key investors in CorNeat Vision include European Innovation Council Fund, Medical Technology Enterprise Consortium.
Will CorNeat Vision IPO soon?
No public IPO plans have been announced for CorNeat Vision.
How can I track CorNeat Vision secondary market activity?
Caplight tracks bids, offers, and trades in CorNeat Vision's shares on secondary markets.